Italian crisis "will slash 13% of medtech workforce by 2015"
This article was originally published in Clinica
Executive Summary
Italy’s medtech industry has lost almost 3% of its workforce since early 2011 as a result of the escalating economic crisis, and is on track to lose a further 13% – some 6,900 staff – by the end of 2015, industry association Assobiomedica has warned, citing a study by its own research centre.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.